Reviewing the use of ethylcellulose, methylcellulose and hypromellose in microencapsulation. Part 3: Applications for microcapsules

References

• Modified-release dosage. Encyclopaedia Britannica. http://www.britannica.com/EBchecked/topic/1312949/modified-release-dosage (accessed October 2010).
   Google Scholar
• Bergisadi N, Gurvardar D. (1989). Studies on piroxicam microcapsules and in vitro release kinetics. Acta Pharmaceutica Turcica, 31:161–165.
   Google Scholar
• Chowdary KPR, Rao GN. (1984). Studies of a new technique of microencapsulation by ethyl cellulose. Ind J Pharmaceut Sci, 46:213–215.
   Google Scholar
• Chowdary KPR, Rao GN. (1985). Studies on a new technique of microencapsulation. Part V: Microencapsulation of aspirin by ethyl cellulose. Ind Drugs, 22:479–481.
   Google Scholar
• Deshpande AV, Njikam AP. (1977). Microencapsulation of paracetamol. Ind J Pharm, 39:76–78.
   Google Scholar
• Jalsenjak I, Nixon JR, Senjkovic R, Stivic I. (1980). Sustained-release dosage forms of microencapsulated isoniazid. J Pharm Pharmacol, 32:678–680.
   PubMed Web of Science ®Google Scholar
• Lin SY, Ho LT, Chiou HL. (1988). Insulin controlled-release microcapsules to prolong the hypoglycemic effect in diabetic rats. Biomater Artif Cells Artif Organs, 16:815–828.
   PubMed Web of Science ®Google Scholar
• Utsuki T, Brem H, Pitha J, Loftsson T, Kristmundsdottir T, Tyler BM, Olivi A. (1996). Potentiation of anticancer effects of microencapsulated carboplatin by hydroxypropyl-α-cyclodextrin. J Controlled Release, 40:251–260.
   Web of Science ®Google Scholar
• General Chapter. (2010). <1151> Pharmaceutical dosage forms. In: USP33-NF28 (through reissue of first supplement). The United States Pharmacopeial Convention.
   Google Scholar
• Collett J, Moreton C. (2002). Modified-release peroral dosage forms. In: Aulton ME, ed. Pharmaceutics: The Science of Dosage Form Design. Philadelphia, PA USA: Churchill Livingstone, 289–305.
   Google Scholar
• Weiss G, Yamaguchi H, Ibuki R, Yasumura M, Ohnishi N. (1998). Microencapsulation of the renin inhibitor FK906 by phase separation of ethylcellulose in cyclohexane. J Microencapsul, 15:335–346.
   PubMed Web of Science ®Google Scholar
• Baichwal MR, Abraham IA. (1980). Microencapsulation of metronidazole. Ind J Pharmaceut Sci, 42, 48–51.
   Google Scholar
• Tsai YH, Huang LC. (1985). [Studies on the microencapsulation of indomethacin by a phase separation technique]. Gaoxiong Yi Xue Ke Xue Za Zhi, 1:551–561.
   PubMedGoogle Scholar
• Jani GK, Chauhan GM, Gohel M, Patel J. (1992). Microencapsulation of indomethacin by complex emulsification. Ind Drugs, 29:450–452.
   Google Scholar
• Assimopoulou AN, Papageorgiou VP. (2004). Preparation and release studies of alkannin-containing microcapsules. J Microencapsul, 21:161–173.
   PubMed Web of Science ®Google Scholar
• Arabi H, Hashemi SA, Fooladi M. (1996). Microencapsulation of allopurinol by solvent evaporation and controlled release investigation of drugs. J Microencapsul, 13:527–535.
   PubMed Web of Science ®Google Scholar
• Chan LW, Heng PW. (1998). Effects of poly(vinylpyrrolidone) and ethylcellulose on alginate microspheres prepared by emulsification. J Microencapsul, 15:409–420.
   PubMed Web of Science ®Google Scholar
• Deasy PB, Brophy MR, Ecanow B, Joy MM. (1980). Effect of ethylcellulose grade and sealant treatments on the production and in vitro release of microencapsulated sodium salicylate. J Pharm Pharmacol, 32:15–20.
   PubMed Web of Science ®Google Scholar
• Dragan D, Airinei A, Carpov A. (1985). Dissolution studies of microencapsulated 4-sulphonamidophenoxyacetic acid: effect of preparative variables on dissolution. J Microencapsul, 2:223–234.
   PubMedGoogle Scholar
• Goto S, Uchida T, Aoyama T. (1985). Preparation and biopharmaceutical evaluation of microcapsules of ampicillin. J Pharmacobio-dyn, 8:270–277.
   PubMedGoogle Scholar
• Singh J, Robinson DH. (1990). Controlled release captopril microcapsules: effect of ethyl cellulose viscosity grade on the in vitro dissolution from microcapsules and tableted microcapsules. J Microencapsul, 7:67–76.
   PubMed Web of Science ®Google Scholar
• Cheu SJ, Chen RR, Chen PF, Lin WJ. (2001). In vitro modified release of acyclovir from ethyl cellulose microspheres. J Microencapsul, 18:559–565.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lee MH, Shim CK. (1984). Preparation and evaluation of ethyl cellulose microcapsules of indomethacin. Arch Pharm Res, 7, 33–40.
   Google Scholar
• Yoon MA, Yong JI. (1987). Pharmaceutical studies on microencapsulated propranolol hydrochloride. Yakche Hakhoechi, 17:67–73.
   Google Scholar
• Zhang ZY, Ping QN, Xiao B. (2000). Microencapsulation and characterization of tramadol-resin complexes. J Control Release, 66:107–113.
   PubMed Web of Science ®Google Scholar
• Abu-Izza KA, Garcia-Contreras L, Lu DR. (1996). Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology. J Pharm Sci, 85:144–149.
   PubMed Web of Science ®Google Scholar
• Amperiadou A, Georgarakis M. (1995). Controlled release salbutamol sulfate microcapsules prepared by emulsion solvent-evaporation technique and study on the release affected parameters. Int J Pharm, 115:1–8.
   Web of Science ®Google Scholar
• Chen H, Wu JC, Chen HY. (1995). Preparation of ethylcellulose microcapsules containing theophylline by using emulsion non-solvent addition method. J Microencapsul, 12:137–147.
   PubMed Web of Science ®Google Scholar
• Chow AHL, Ho SSS, Tong HHY, Ma HHM. (1998). Parameters affecting in-liquid drying microencapsulation and release rate of cefaclor. Int J Pharm, 172:113–125.
   Web of Science ®Google Scholar
• Chowdary KPR, Murty ASR. (1985). Controlled nitrofurantoin release through microencapsulation. Ind J Pharmaceut Sci, 47:161–162.
   Google Scholar
• D’Onofrio GP, Oppenheim RC, Bateman NE. (1979). Encapsulated microcapsules. Int J Pharm, 2:91–99.
   Web of Science ®Google Scholar
• Ibrahim SA, Sayed HA, Hafez E, El-SayedAM, Ali SS. (1990). Preparation and evaluation of sustained release ethyl cellulose encapsulated aspirin. Bulletin of Pharmaceutical Sciences, Assiut University, 13:235–246.
   Google Scholar
• Ku YS, Kang HH. (1991). Microencapsulation of propranolol hydrochloride with ethylcellulose by solvent evaporation method in liquid paraffin. Nonchong - Han’guk Saenghwal Kwahak Yonguwon, 48:109–128.
   Google Scholar
• Murav’ev IA, Andreeva IN. (1987). The effect of microencapsulation on release rate of euphylline from tablets. Farmatsiya (Moscow, Russian Federation), 36:19–21.
   Google Scholar
• Nasa SL, Yadav S. (1989). Microencapsulation of metoprolol tartrate using phase separation coacervation techniques. Eastern Pharmacist, 32:133–134.
   Google Scholar
• Öner L, Yalabik-Kas HS, Hincal AA. (1983). Microencapsulation and in vitro dissolution kinetics of dihydralazine sulfate. Conference proceedings: Expo. - Congr. Int. Technol. Pharm., 3rd, Assoc. Pharm. Galenique Ind.
   Google Scholar
• Öner L, Yalabik-Kas S, Cave G, Hincal AA. (1984). Microencapsulation and in vitro dissolution kinetics of dihydralazine sulfate. Labo-Pharma - Problemes et Techniques, 346:690–693.
   Google Scholar
• Rak J, Vitkova M, Chalabala M, Heliova M. (1984). Study on drug microforms. X. Manufacture and in vitro evaluation of ethyl cellulose microcapsules with sulfamethoxydiazine. Farmaceuticky Obzor, 53:445–454.
   Google Scholar
• Sajeev C, Vinay G, Archna R, Saha RN. (2002). Oral controlled release formulation of diclofenac sodium by microencapsulation with ethyl cellulose. J Microencapsul, 19:753–760.
   PubMed Web of Science ®Google Scholar
• Salib NN. (1973). Microencapsulation and flocculation techniques in pharmaceutical formulation. III. Quantitative determination of the effect of coating/core ratio on drug release from phenobarbitone microcapsules and floccules. Pharmazeutische Industrie, 35:217–219.
   Google Scholar
• Salib NN, El-menshaway ME, Ismail AA. (1976). Ethyl cellulose as a potential sustained release coating for oral pharmaceuticals. Pharmazie, 31:721–723.
   PubMed Web of Science ®Google Scholar
• Suryakusuma H, Jun HW. (1984). Encapsulated hydrophilic polymer beads containing indomethacin as controlled release drug delivery systems. J Pharm Pharmacol, 36:497–501.
   PubMed Web of Science ®Google Scholar
• Vitkova M, Chalabala M, Rak J, Heliova M. (1984). Drug microforms. VII. Microcapsules of chloramphenicol. Farmaceuticky Obzor, 53:241–250.
   Google Scholar
• Aly AM, Saleh SI, Ahmed SM, Abdel-Rahaman SI, Aboutaleb AE. (1993). Microencapsulation of nitrofurantoin by coacervation using certain polymeric materials. Bulletin of Pharmaceutical Sciences, Assiut University, 16:73–87.
   Google Scholar
• Chowdhary KPR, Ramesh KVRNS. (1993). Studies on microencapsulation of diltiazem. Ind J Pharmaceut Sci, 55:52–54.
   Google Scholar
• Chowdary KPR, Ratna JV. (1993). A comparative evaluation of ethylcellulose, methylcellulose, and cellulose acetate microcapsules prepared by a complex emulsion method. Ind Drugs, 30:179–84.
   Google Scholar
• Nixon JR, Agyilirah GA. (1982). The effect of polyisobutylene on the properties of ethyl cellulose-walled microcapsules of phenobarbitone sodium. Acta Pharmaceutica Technologica, 28:137–140.
   Google Scholar
• Sakr FM. (1991). Studies on microencapsulated granules: effect of drug-binder solubilities and added diluents on core properties and microencapsulation characteristics. J Drug Res, 20:303–313.
   Google Scholar
• Singh J, Robinson DH. (1988). Controlled release captopril microcapsules: effect of non-ionic surfactants on release from ethyl cellulose microcapsules. J Microencapsul, 5:129–137.
   PubMed Web of Science ®Google Scholar
• Uchida T, Fujimoto I, Goto S. (1989). Biopharmaceutical evaluation of sustained-release ethylcellulose microcapsules containing amoxicillin using beagle dogs. Chem Pharm Bull, 37:3416–3419.
   PubMed Web of Science ®Google Scholar
• Wu JC, Jean WJ, Chen H. (1993). Preparation and release behavior of ethylcellulose microcapsules containing theophylline dispersed in cellulose triacetate matrixes. J Chin Chem Soc, 40:23–28.
   Web of Science ®Google Scholar
• Wu JC, Jean WJ, Chen H. (1994). Evaluation of the properties of ethylcellulose-cellulose triacetate microcapsules containing theophylline prepared by different microencapsulation techniques. J Microencapsul, 11:507–518.
   PubMed Web of Science ®Google Scholar
• Yalabik-Kas HS. (1983). Microencapsulation and in vitro dissolution of oxazepam from ethyl cellulose microcapsules. Drug Dev Ind Pharm, 9:1047–1060.
   Web of Science ®Google Scholar
• Baker RW, Lonsdale HK. (1974). Controlled Release of Biologically Active Agents. New York: Plenum Press.
   Google Scholar
• Martin A, Bustamante P, Chun AHC. (1993). Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. In: Martin A, Bustamante P, and Chun AHC, eds. Diffusion and dissolution. Baltimore, MD USA: Williams & Wilkins, 324–361.
   Google Scholar
• Chemtob C, Chaumeil JC, N’Dongo M. (1986). Tablets of metronidazole microcapsules: release characteristics. Int J Pharm, 29:83–92.
   Web of Science ®Google Scholar
• Chemtob C, Chaumeil JC, N’Dongo M. (1986). Microencapsulation by ethyl cellulose phase separation: microcapsule characteristics. Int J Pharm, 29:1–7.
   Web of Science ®Google Scholar
• Dubernet C, Benoit JP, Peppas NA, Puisieux F. (1990). Ibuprofen-loaded ethylcellulose microspheres: release studies and analysis of the matrix structure through the Higuchi model. J Microencapsul, 7:555–565.
   PubMed Web of Science ®Google Scholar
• Hasan M, Najib N, Suleiman M, El-Sayed Y, Abdel-Hamid M. (1992). In vitro and in vivo evaluation of sustained-release and enteric-coated microcapsules of diclofenac sodium. Drug Dev Ind Pharm, 18:1981–1988.
   Web of Science ®Google Scholar
• Hasçiçek C, Gönül N, Erk N. (2003). Mucoadhesive microspheres containing gentamicin sulfate for nasal administration: preparation and in vitro characterization. Farmaco, 58:11–16.
   PubMedGoogle Scholar
• Lavasanifar A, Ghalandari R, Ataei Z, Zolfaghari ME, Mortazavi SA. (1997). Microencapsulation of theophylline using ethylcellulose: in vitro drug release and kinetic modelling. J Microencapsul, 14:91–100.
   PubMed Web of Science ®Google Scholar
• Lin SY. (1985). Influence of coacervation-inducing agents and cooling rates on the preparation and in vitro release of bleomycin hydrochloride microcapsules. J Microencapsul, 2:91–101.
   PubMedGoogle Scholar
• Lin S-Y, Yang JC. (1986). Studies on microencapsulation. Part IV. Effect of ethylene-vinyl acetate as a coacervation-inducing agent on the production and release behavior of chlorpromazine hydrochloride microcapsules and tabletted microcapsules. J Controlled Release, 3:221–228.
   Google Scholar
• Rao KR, Senapati P, Das MK. (2005). Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine. J Microencapsul, 22:863–876.
   PubMed Web of Science ®Google Scholar
• Yang C-Y, Tsay S-Y, Chen B-K. (2001). Application of gelatin for encapsulating aspirin into ethylcellulose microcapsule in an O/W emulsion. Chem Eng Commun, 186:241–255.
   Web of Science ®Google Scholar
• Lin SY, Chen FJ. (1992). Cooling rate affecting the formation and properties of theophylline ethylcellulose microcapsules prepared by phase separation method. Pharm Acta Helv, 67:91–96.
   Google Scholar
• Lippold BH, Sutter BK, Lippold BC. (1989). Parameters controlling drug release from pellets coated with aqueous ethyl cellulose dispersion. Int J Pharm, 54:15–25.
   Web of Science ®Google Scholar
• Nakajima T, Takashima Y, Iida K, Mitsuta H, Koishi M. (1987). Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin. Chem Pharm Bull, 35:1201–1206.
   PubMed Web of Science ®Google Scholar
• Powell TC. (1993). Controlled-release calcium channel blocker microcapsules. US 5252337 A.
   Google Scholar
• Uchida T, Yasutake T, Goto S. (1992). Utility of mixture of commercially available polymers as constituents of sustained-release microcapsules containing cefadroxil or theophylline. Chem Pharm Bull, 40:463–466.
   PubMed Web of Science ®Google Scholar
• Sinclair GW, Peppas NA. (1984). Analysis of non-Fickian transport in polymers using simplified exponential expressions. J Membrane Sci, 17:329–331.
   Web of Science ®Google Scholar
• Peppas NA. (1985). Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 60:110–111.
   PubMedGoogle Scholar
• Korsmeyer RW, Lustig SR, Peppas NA. (1986). Solute and penetrant diffusion in swellable polymers. I. Mathematical modeling. J Polymer Sci B, 24:395–408.
   Web of Science ®Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks. J Controlled Release, 5:23–36.
   Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Controlled Release, 5:37–42.
   Google Scholar
• Brannon-Peppas L, Peppas NA. (1989). Dynamic swelling behavior of pH-sensitive swelling controlled release systems. Conference proceedings: Congr. Int. Technol. Pharm., 5th, Assoc. Pharm. Galenique Ind.
   Google Scholar
• Peppas NA, Sahlin JJ. (1989). A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm, 57:169–172.
   Web of Science ®Google Scholar
• Mallick S, Roy K, Chakraborty A, Saha S. (2002). Mechanism of in vitro release kinetics of flurbiprofen loaded ethylcellulose micropellets. Acta Pol Pharm, 59:193–198.
   PubMedGoogle Scholar
• Oner L, Kas HS, Hincal AA. (1988). Studies on zinc sulphate microcapsules (1): Microencapsulation and in vitro dissolution kinetics. J Microencapsul, 5:219–223.
   PubMed Web of Science ®Google Scholar
• Langenbucher F. (1976). Parametric representation of dissolution-rate curves by the RRSBW distribution. Pharmazeutische Industrie, 38:472–477.
   Google Scholar
• Cameroni R, Coppi G, Forni F, Iannuccelli V, Bernabei MT. (1985). [Sulfadiazine: release from microcapsules]. Boll Chim Farm, 124:393–400.
   PubMedGoogle Scholar
• Chen H, Wu J-C, Chang C-L. (1994). Preparation and release behavior of cellulose triacetate-ethylcellulose microcapsules containing theophylline by using emulsion nonsolvent addition method. Huaxue, 52:301–310.
   Google Scholar
• Farivar M, Kas HS, Oner L, Hincal AA. (1993). Factorial design-based optimization of the formulation of isosorbide-5-mononitrate microcapsules. J Microencapsul, 10:309–317.
   PubMed Web of Science ®Google Scholar
• Guyot M, Fawaz F. (1998). Nifedipine loaded-polymeric microspheres: preparation and physical characteristics. Int J Pharm, 175:61–74.
   Web of Science ®Google Scholar
• Kristl A, Bogataj M, Mrhar A, Kozjek F. (1991). Preparation and evaluation of ethyl cellulose microcapsules with bacampicillin. Drug Dev Ind Pharm, 17:1109–1130.
   Web of Science ®Google Scholar
• Nixon JR, Wong KT. (1990). Evaluation of drug permeation through polymeric membranes as a model for release. (II). Ethyl cellulose-walled microcapsules. Int J Pharm, 58:31–40.
   Web of Science ®Google Scholar
• Ruiz R, Sakr A, Sprockel OL. (1990). A study on the manufacture and in vitro dissolution of terbutaline sulfate microcapsules and their tablets. Drug Dev Ind Pharm, 16:1829–1842.
   Web of Science ®Google Scholar
• Sevgi F, Ozyazici M, Güneri T. (1994). Sustained-release dosage form of phenylpropanolamine hydrochloride. Part II: Formulation and in vitro release kinetics from tableted microcapsules. J Microencapsul, 11:335–344.
   PubMed Web of Science ®Google Scholar
• Yang CY, Tsay SY, Tsiang RC. (2001). Encapsulating aspirin into a surfactant-free ethyl cellulose microsphere using non-toxic solvents by emulsion solvent-evaporation technique. J Microencapsul, 18:223–236.
   PubMed Web of Science ®Google Scholar
• Snipes WC, Wagner SJ. (1989). Controlled release potassium chloride composition. US 4832955.
   Google Scholar
• Goto S, Moriya F, Kawata M, Kimura T. (1984). Preparation and biopharmaceutical evaluation of microcapsules of amoxicillin. J Microencapsul, 1:137–155.
   PubMedGoogle Scholar
• Itoh M, Nakano M, Juni K, Sekikawa H. (1980). Sustained release of sulfamethizole, 5-fluorouracil, and doxorubicin from ethylcellulose-polylactic acid microcapsules. Chem Pharm Bull, 28:1051–1055.
   Web of Science ®Google Scholar
• Georgiev G, Valova N, Tarkalanov N, Parusheva K, Kostova I. (1994). Regulation of the microencapsulated ampicillin trihydrate released from calcium alginate gel matrix. Godishnik na Sofiiskiya Universitet “Sv. Kliment Okhridski”, Khimicheski Fakultet, 81, 107–116.
   Google Scholar
• Ghorab MM, Zia H, Luzzi LA. (1990). Preparation of controlled release anticancer agents. I: 5-Fluorouracil-ethyl cellulose microspheres. J Microencapsul, 7:447–454.
   PubMed Web of Science ®Google Scholar
• Goto S, Tsuruta M, Sato H, Nakayama T. (1973). Evaluation of microcapsules. I. Yakuzaigaku, 33:95–100.
   Google Scholar
• Lippold BC, Förster H. (1982). Entwicklung, herstellung und in-vitro-testung von peroralen depotarzneiformen mit konstanter wirkstoffliberation am beispiel des theophyllins. Pharmazeutische Industrie, 44:735–740.
   Google Scholar
• Cohen EC. (1986). Microencapsulated astringent hemostatic agents and their use. US 4597960 A.
   Google Scholar
• Ducroux P, Aiache S, Renoux R, Aiache JM. (1984). Study on the bioavailability of acetylsalicylic acid gelatin capsules. Conference proceedings: Biopharm. Pharmacokinet., Eur. Congr., 2nd, Lavoisier.
   Google Scholar
• Gold O. (2001). Prolonged-release microgranules for 4-nitro-2-phenoxymethanesulfonanilide. EP 1269998 A1.
   Google Scholar
• Rak J, Vitkova M, Chalabala M, Szechenyi S, and Heinrich J. (1984). Study on drug microforms. XI. Biopharmaceutical evaluation of ethyl cellulose microcapsules with sulfamethoxydiazine. Farmaceuticky Obzor, 53:515–521.
   Google Scholar
• Eley JG, Whateley TL, Goldberg JA, Kerr DJ, McArdle CS, Anderson J, Kato T. (1992). Microencapsulation of mitomycin C using ethylcellulose and its evaluation in patients with liver metastases. Drug Target Deliv, 1:293–303.
   Google Scholar
• Kato T, Nemoto R. (1978). Microencapsulation of mitomycin C for intraarterial infusion chemotherapy. Proceedings of the Japan Academy, Series B: Physical and Biological Sciences, 54:413–417.
   Web of Science ®Google Scholar
• Okamoto Y, Konno A, Togawa K, Kato T, Tamakawa Y, Amano Y. (1986). Arterial chemoembolization with cisplatin microcapsules. Br J Cancer, 53:369–375.
   PubMed Web of Science ®Google Scholar
• Shindo M. (1988). Microencapsulated anticancer drug. Experimental studies on microencapsulation of peplomycin and application to arterial microchemoembolization. Akita Igaku, 15:531–541.
   Google Scholar
• Kato T, Unno K, Goto A. (1985). Ethylcellulose microcapsules for selective drug delivery. Meth Enzymol, 112:139–150.
   PubMed Web of Science ®Google Scholar
• Putcha L, McDonough J, Boland EJ, Dixon H, Persyn JT, Vasisht N. (2005). Controlled release compositions and methods for using same. WO 2003105811 A8.
   Google Scholar
• Ranga Rao KV, Buri P. (1989). A novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm, 52:265–270.
   Web of Science ®Google Scholar
• Safwat SM, El-Shanawany S. (1989). Evaluation of sustained-release suppositories containing microencapsulated theophylline and oxyphenbutazone. J Controlled Release, 9:65–73.
   Web of Science ®Google Scholar
• Ayer AD, Yieh RLC, Pollack BJ, Wong PSL. (1994). Valproate for sustained antiepileptic therapy. WO 9427587 A3.
   Google Scholar
• Curea E, Ban I, Leucuta ES, Bojita M, Cardan E. (1987). Effect of buffering and microencapsulation of acetylsalicylic acid on dissolution rate and bioavailability. Farmacia (Bucharest, Romania), 35:75–82.
   Google Scholar
• Guo J, Xu H. (1998). Preparation and pharmacokinetics of sustained-release isoniazid. Zhongguo Yaoxue Zazhi (Beijing), 33:95–98.
   Google Scholar
• Karakasa I, Yagi N, Shibata M, Kenmotsu H, Sekikawa H, Takada M. (1994). Sustained release of phenytoin following the oral administration of phenytoin sodium/ethylcellulose microcapsules in human subjects and rabbits. Biol Pharm Bull, 17:432–436.
   PubMed Web of Science ®Google Scholar
• Nikolayev AS, Gebre-Mariam T. (1993). Preparation and bioavailability studies of aspirin ethylcellulose microcapsules. Ind Drugs, 30:392–397.
   Google Scholar
• Shopova S, Tomova V, Radeva K, Ateva P, Tyutyulkova N, Gorancheva Y. (1987). Controlled release of acetylsalicylic acid from Aspropharm tablets. Farmatsiya (Sofia, Bulgaria), 37:22–27.
   Google Scholar
• Biju SS, Saisivam S, Rajan NS, Mishra PR. (2004). Dual coated erodible microcapsules for modified release of diclofenac sodium. Eur J Pharm Biopharm, 58:61–67.
   PubMed Web of Science ®Google Scholar
• Portnyagina VA, Fedorova IP, Pochinok TV, Tarahovskii ML, Zadorozhnaya TD, Yatsenko KV. (1991). Microcapsules of sodium 2,3-dimercaptopropane sulfonate (unithiol). Farmatsiya (Moscow, Russian Federation), 24–27.
   Google Scholar
• Tsujiyama T, Suzuki N, Kuriki T, Kawata M, Goto S. (1990). Pharmacological evaluation of hydroxypropylcellulose-ethylcellulose microcapsules containing piretanide. J Pharmacobio-dyn, 13:1–9.
   PubMedGoogle Scholar
• Hu Z, Kimura G, Ito Y, Mawatari S, Shimokawa T, Yoshikawa H et al. (1999). Technology to obtain sustained release characteristics of drugs after delivered to the colon. J Drug Target, 6:439–448.
   PubMed Web of Science ®Google Scholar
• Kato T. (1981). Enhancement of antitumor effects by magnetic control of microencapsulated anticancer drug. Gan To Kagaku Ryoho, 8:698–706.
   Google Scholar
• Kimura G, Hu Z, Mawatari S, Shimokawa T, Takada K. (1999). Technology to obtain sustained-release characteristics of drugs after delivery to the colon. Drug Deliv Syst, 14:191–196.
   Google Scholar
• Nemoto R, Kato T. (1981). Experimental intra-arterial infusion of Microencapsulated Mitomycin C into pelvic organs. Br J Urol, 53:225–227.
   PubMedGoogle Scholar
• Nemoto R, Kato T. (1984). Microencapsulation of anticancer drug for intraarterial infusion, and its clinical application. Conference proceedings: Microspheres Drug Ther. Pharm., Immunol., Med. Aspects, Elsevier.
   Google Scholar
• Beatty ML. (1982). Powdered microencapsulated bacampicillin acid addition salt and oral suspensions containing it. US 4321253 A.
   Google Scholar
• Morishita M, Ohno M, Sumita Y, and Soejima R. (1985). Formulation design of rokitamycin (TMS-19-Q) tablet and its evaluation. Conference proceedings: Recent Adv. Chemother., Proc. Int. Congr. Chemother., 14th, University Tokyo Press.
   Google Scholar
• Murgu L, Oita M, Dogaru I. (1981). New pharmaceutical forms of aspirin. Experimental pharmacodynamic study. Farmacia (Bucharest, Romania), 29:229–238.
   Google Scholar
• Tuncel T, Bergsadi N, Akin L, Otük G, Kusçu I. (1996). In vitro and in vivo studies on microcapsules and tabletted microcapsules of cephradine. Pharmazie, 51:168–171.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zou L, Qi H, Liu D. (1993). Studies of the preparation of sodium ampicillin-ethylcellulose microcapsules and the bioavailability in rabbits. Shandong Yike Daxue Xuebao, 31:71–73.
   Google Scholar
• Echigo M, Murota H, Goto A, Unno K, Kato T, Nemoto R, Mori H, Homma M. (1982). Microencapsulation of neoplasm inhibitors. 2. Preparation and characteristic of the ferromagnetic microcapsules. Byoin Yakugaku, 8:242–245.
   Google Scholar
• Kato T, Nemoto R, Mori H, Unno K, Goto A, Harada M, Homma M. (1979). Preparation and characterization of ferromagnetic mitomycin C microcapsules as a means of the magnetic control of anticancer drugs. Proceedings of the Japan Academy, Series B: Physical and Biological Sciences, 55:470–475.
   Web of Science ®Google Scholar
• Matsumoto K, Ugajin Y. (1989). Microencapsulation of pharmaceuticals with magnetic substances, and preparation of enzyme-bound magnetic microcapsules. JP 02229545 A2.
   Google Scholar
• Rao MR, Borate SG, Thanki KC, Ranpise AA, Parikh GN. (2009). Development and in vitro evaluation of floating rosiglitazone maleate microspheres. Drug Dev Ind Pharm, 35:834–842.
   PubMed Web of Science ®Google Scholar
• Barzola G, Piacentini D, Wexler P. (2001). Microencapsulation of secnidazole by fluid-bed coating: relation between taste masking and coating membrane thickness. Revista SAFYBI, 40:21–27.
   Google Scholar
• Dahlstrom H, Eriksson S. (1971). Effect of microencapsulation with ethyl cellulose upon the disintegration in vivo and the dissolution of iron tablets. Acta Pharm Suec, 8:505–508.
   PubMedGoogle Scholar
• Lippmann I, Popli SD, Miller LG, Bell LG. (1981). Controlled release potassium dosage form. US 4259315 A.
   Google Scholar
• Vitkova M, Chalabala M, Rak J, Pikulikova Z. (1986). Studies of drug microforms. XIII. Tablets with potassium chloride from ethyl cellulose microcapsules. Cesko-Slovenska Farmacie, 35:171–175.
   Google Scholar
• Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. (2002). Formulation and physicochemical evaluation of diclofenac sodium chewable tablets. Saudi Pharmaceut J, 10:177–183.
   Google Scholar
• Alpar OH. (1981). Sustained-release characteristics of tablets of ethylcellulose microcapsules containing potassium phenethicillin. Farmaco Prat, 36:366–373.
   PubMedGoogle Scholar
• Gantt M, Venkatesh GM, Vishnupad KS. (2000). Controlled release potassium chloride tablet formulations. WO 2001043725 A1.
   Google Scholar
• Hosny EA, Al-Helw AA-RM, Niazy EM. (1998). In-vitro and in-vivo evaluation of commercial and microencapsulated sustained-release tablets containing diclofenac sodium. Saudi Pharmaceut J, 6:65–70.
   Google Scholar
• Kondo A, Miyano S, Kitajima M, Arai F. (1972). Encapsulated aspirin tablets. JP 49062623 A2.
   Google Scholar
• Morre DM, Morre DJ, Cooper R, Chang MN. (2002). Tea catechins in sustained release formulations as cancer specific proliferation inhibitors. US 6410052 B1.
   Google Scholar
• Raghubanshi RS, Jayaswal SB, Singh J. (1991). Controlled-release tablets of ethyl cellulose coated salbutamol sulphate microcapsules. Pharmazie, 46:144–145.
   PubMed Web of Science ®Google Scholar
• Tirkkonen S, Paronen P. (1993). Release of indomethacin from tabletted ethylcellulose microcapsules. Int J Pharm, 92:55–62.
   Google Scholar
• Venkatesh G, Kramer C. (2003). Controlled release potassium chloride tablets. US 20050013860 A1.
   Google Scholar
• Yazan Y, Demirel M, Güler E. (1995). Preparation and in vitro dissolution of salbutamol sulphate microcapsules and tabletted microcapsules. J Microencapsul, 12:601–607.
   PubMed Web of Science ®Google Scholar
• Zia H, Falamarzian M, Raisi A, Montaseri H, Needham TE. (1991). Biopharmaceutical evaluation of a tablet dosage form made from ethyl cellulose encapsulated aspirin particles. J Microencapsul, 8:21–28.
   PubMed Web of Science ®Google Scholar
• Vitkova M, Chalabala M, Rak J, Prochazka R. (1994). Ethylcellulose to prepare a matrix system of a hydrophilic drug by the microencapsulation process. STP Pharma Sci, 4:486–491.
   Google Scholar
• Özyazici M, Sevgi F, Ertan G. (1996). Micromeritic studies on nicardipine hydrochloride microcapsules. Int J Pharm, 138:25–35.
   Web of Science ®Google Scholar
• General Chapter. (2010). <1174> Powder flow. In: USP33-NF28 (through reissue of first supplement). The United States Pharmacopeial Convention.
   Google Scholar
• Anderson JL. (1971). Report: Microencapsulated cloud seeding materials. Capsular Res. Prod. Dev. Dep., Natl. Cash Register Co., Dayton, OH, USA: US Clearinghouse Fed. Sci. Tech. Inform.
   Google Scholar
• Bhalerao SS, Lalla JK, Rane MS. (2001). Study of processing parameters influencing the properties of diltiazem hydrochloride microspheres. J Microencapsul, 18:299–307.
   PubMed Web of Science ®Google Scholar
• Harte KM. (1978). Folic acid animal feed materials. US 4087556 A.
   Google Scholar
• Kallstrand AGV, Mattsson KJ, Sjoqvist RI. (1986). Controlled release oral mixtures containing microencapsulated pharmaceuticals. GB 2122490 B2.
   Google Scholar
• Kantor ML, Steiner SS, Pack HM. (1989). Microencapsulation of fish oil. EP 336662 A3.
   Google Scholar
• Rani KNS, Goundalkar AG, Prakasam K. (1994). Preparation and evaluation of microspheres of diclofenac sodium. Ind J Pharmaceut Sci, 56:45–50.
   Google Scholar
• Yokoyama T, Shibata K. (1987). Microencapsulated alkaline earth sulfide phosphors. JP 63178194 A2.
   Google Scholar
• Kassem AA, Badawy AA, El-Sayed AA. (1975). Microencapsulation of L-ascorbic acid. Bulletin of the Faculty of Pharmacy (Cairo University), 12:11–24.
   Google Scholar
• Palomo ME, Ballesteros MP, Frutos P. (1996). Solvent and plasticizer influences on ethylcellulose-microcapsules. J Microencapsul, 13:307–318.
   PubMed Web of Science ®Google Scholar
• Wang Y-J, Liu C-B, Bai G-Y, Chu Y, Wang F-P, Ma Z-F, Zhang H-Z. (1996). Microcapsule-immobilized catalase. Gaodeng Xuexiao Huaxue Xuebao, 17:953–956.
   Google Scholar
• Sakuma S, Atsumi K. (1990). Anticariogenic dentifrices containing microencapsulated hydroxylapatite and microencapsulated fluoride. DE 3821256 A1.
   Google Scholar
• Singla AK, Nagrath A. (1988). Stability of ascorbic acid-zinc sulfate tablets. Drug Dev Ind Pharm, 14:1471–1479.
   Web of Science ®Google Scholar
• Al-Omran MF, Al-Suwayeh SA, El-Helw AM, Saleh SI. (2002). Taste masking of diclofenac sodium employing four different techniques. Saudi Pharmaceut J, 10:106–113.
   Google Scholar
• Alpar HO, Walters V. (1981). The prolongation of the in vitro dissolution of a soluble drug (phenethicillin potassium) by microencapsulation with ethyl cellulose. J Pharm Pharmacol, 33:419–422.
   PubMed Web of Science ®Google Scholar
• Chikamatsu Y, Ando Y, Hasebe K, Hayashi K. (1984). Microencapsulation of tryptophan. JP 01040011 B4.
   Google Scholar
• Chukwu A, Agarwal SP, Adikwu MU. (1991). Some properties of chloroquine phosphate and quinine hydrochloride microcapsules. STP Pharma Sci, 1:117–120.
   Google Scholar
• Golzi R, Boltri L, and Stollberg C. (2004). Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer. WO 2004105725 A3.
   Google Scholar
• Yokota Y, Ishibashi K, Yamada K, Tanaka S, Pondevida JL, Dominguez LG, Lalusis BM, Pigao CG, Panlasigui RA. (1994). Preparation and performance of slow release microcapsules containing nutrient by complex emulsion method. Philippine J Sci, 123:121–133.
   Google Scholar
• Baichwal MR, Chidambharam PP. (1977). Ascorbic acid protection by embedding. Ind J Pharm, 39:129–132.
   Google Scholar
• Szretter D, Zakrzewski Z. (1987). Technology of ascorbic acid microencapsulation. Acta Pol Pharm, 44:352–356.
   Google Scholar
• Morse LD, Hammes PA. (1972). Comestible fat product containing nutrition-enriching iron encapsulated to prevent rancidness. FR 2107697.
   Google Scholar
• Morse LD, Hammes PA. (1974). Microencapsulated product. ZA 7207752 A.
   Google Scholar
• Anonymous. Stabilization of vitamins and minerals by microencapsulation. (1974). NL 7215117 A.
   Google Scholar
• Zhelyazkova Zh, Dilov P, Chakarov R, Isaev I. (1985). Drug forms with microencapsulated iron (II) sulfate. Problemi na Farmatsiyata, 13:49–55.
   Google Scholar
• He F, Hou H. (1989). Preparation of vitamin C microcapsule. Zhongguo Yiyao Gongye Zazhi, 20:462–464.
   Google Scholar
• Kozlova IV, Dontsova GI, Chlenov VA, Lebedenko VIa, Griadunova GP. (1977). [Microencapsulation process for water-soluble vitamins]. Farmatsiia, 26:37–39.
   PubMedGoogle Scholar
• 7 fish oil benefits proven by research. http://ezinearticles.com/?7-Fish-Oil-Benefits-Proven-by-Research&id=415032 (accessed September 2007).
   Google Scholar
• Tanaka N. (1978). Photodecomposable microcapsules. JP 54109078 A2.
   Google Scholar
• Dailey OD Jr, Dowler CC. (1995). Polymeric microcapsules of selected herbicides: preparation and efficacy. Trends Org Chem, 5:83–102.
   Google Scholar
• Dailey OD Jr, Dowler CC. (1996). Herbicidal evaluation of polymeric microcapsules of cyanazine. Part II. Conference proceedings: 212th ACS National Meeting, American Chemical Society.
   Google Scholar
• Fernandez-Urrusuno R, Gines JM, Morillo E. (2000). Development of controlled release formulations of alachlor in ethylcellulose. J Microencapsul, 17:331–342.
   PubMed Web of Science ®Google Scholar
• Jouffroy C. (1984). Rodenticide formulation containing scilliroside. FR 2496403 B1.
   Google Scholar
• Nelson LD. (1974). Weather modification using microencapsulated material. US 399009.
   Google Scholar
• Williams D, Meier PM, Gron P, Hitchcock CJ, Mullins TJ, Bowen WH. (1982). Cariostatic microcapsules for aerosol delivery. J Pedod, 6:218–228.
   PubMedGoogle Scholar
• Ahlert G, Evert S. (1995). Medicated dental floss containing oxygen generating agent. US 5423337 A.
   Google Scholar
• Wikipedia website. Web address: http://en.wikipedia.org/wiki/ (accessed September 2007).
   Google Scholar
• Kimura T. (1971). Dampening process for offset printing. DE 2113452 A.
   Google Scholar
• Anonymous. Method for fabrication of microencapsulated toners. (1983). JP 60120367 A2.
   Google Scholar
• Kitakoji T, Yoneda Y, Murakawa K. (1973). Double-wall microencapsulation for pressure-sensitive copying paper. JP 49121786 A2.
   Google Scholar
• Witz I. (1982). Microcapsules for pressure sensitive recording materials. GB 2017624 B.
   Google Scholar
• Pandell NW, Temin SC. (1972). Application of reactants and/or catalysts to textile fabrics in microencapsulated form. US 3632296 A.
   Google Scholar
• Cowsar DR, Lewis DH, Whitehead GW. (1978). Report: Study of reactive materials for development of new protective clothing concepts. South. Res. Inst., Birmingham, AL, USA: Gov. Rep. Announce. Index (U.S.).
   Google Scholar
• Cowsar DR. (1980). Fabric containing microcapsules of chemical decontaminants encapsulated within semipermeable polymers. US 4201822 A.
   Google Scholar
• Charle R, Zviak C, Kalopissis G. (1973). Cosmetic composition containing nail polish solvents enclosed in microcapsules. FR 2033292 B3.
   Google Scholar
• Gentilini L. (1986). Deodorant containing tannic acid microcapsules with modulating effect on perspiration. EP 201134 A3.
   Google Scholar
• Takada K. (2000). Nonoral micro- or milli-capsules having three-layer structure, and manufacture thereof. WO 2001089486 A1.
   Google Scholar
• Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50:874–875.
   PubMed Web of Science ®Google Scholar
• Adikwu MU. (1995). Release behavior from latex-treated, matrix tablet formulations. Pharmakeutike, 8:83–88.
   Google Scholar
• Hsiao C, Chou C-TK. (1989). Controlled release potassium chloride. US 4863743 A.
   Google Scholar
• Ishibashi K, Yamada K, Noda Y, Shigashide F. (1985). Preparation of medicinal carbon and microcapsules containing acetylsalicylic acid on medicinal carbon. Pharmazeutische Industrie, 47:1185–1189.
   Web of Science ®Google Scholar
• Samejima M, Hirata G, Koida Y, Kobayashi Y, Kida A. (1985). Enteric microcapsules. EP 77956 B1.
   Google Scholar
• Uchida T, Goto S. (1988). Biopharmaceutical evaluation of sustained-release ethylcellulose microcapsules containing cefadroxil and cephradine using beagle dogs. Chem Pharm Bull, 36:2135–2144.
   PubMed Web of Science ®Google Scholar
• Maysinger D and Jalsenjak I. (1983). In situ absorption and in vitro release of microencapsulated cimetidine. Int J Pharm, 17:129–134.
   Google Scholar
• Morales ME, Ruiz MA, López G, Gallardo V. (2010). Development of oral suspensions of microparticles of ethylcellulose with tramadol. Drug Dev Ind Pharm, 36:885–892.
   PubMed Web of Science ®Google Scholar
• Yalabik-Kas HS. (1983). Microencapsulation of 1,4-benzodiazepin-2-one derivatives. Oxazepam. Doga Bilim Dergisi, Seri C: Tip, 7:75–84.
   Google Scholar
• Goto S. (1994). Pharmacokinetic considerations related to the bioavailability of sustained-release microencapsulated drugs for oral use. Conference proceedings: 9th International Symposium on Microencapsulation, Ed. Sante.
   Google Scholar
• Wang Y, Bai G, Sun W, Zhang H. (1993). Extraction of chromium (VI) by trioctylamine microcapsule. Yingyong Huaxue, 10:53–55.
   Google Scholar
• Wang Y, Bai G, Xie P, Zhang H. (1993). Method on microencapsulation of α-1,4-glucan-4-glucanohydrolase. Mo Kexue Yu Jishu, 13:40–45.
   Google Scholar
• Wang YJ, Liu CB, Bai GY, Chu Y, Wu ZS, Chang HZ. (1995). Immobilization of catalase with ethylcellulose microcapsule. Shengwu Huaxue Zazhi, 11:201–204.
   Google Scholar
• Nikolaev AS, Vinogradova LF, Kamenskaya MV. (1990). Biopharmaceutical examinations of dosage forms of microencapsulated acetylsalicylic acid. Farmatsiya (Moscow, Russian Federation), 39:20–24.
   Google Scholar
• Farid DJ, Blourchian N, Nokhodchi. (1994). Study of agents affecting the physical properties of aspirin-tableted microcapsules. J School Pharm Med Sci Univ Tehran, 4:27–39.
   Google Scholar
• Fekete PI. (1992). The effect of surfactants on the properties of microcapsules. Drug Target Deliv, 1:55–63.
   Google Scholar
• Heintz T, Teipel U. (2000). Coating of particulate energetic materials. Conference proceedings: International Annual Conference of Fraunhofer-Institut fur Chemische Technologie, Fraunhofer-Institut fur Chemische Technologie.
   Google Scholar
• Vitek R. (1978). Clean grip, pressure-sensitive adhesive tape or film. DE 2820051 A1.
   Google Scholar
• Carr RL Jr. (1965). Evaluating flow properties of solids. Chem Eng, 72:163–168.
   Google Scholar
• Cedrati N, Bonneaux F, Labrude P, Maincent P. (1997). Structure and stability of human hemoglobin microparticles prepared with a double emulsion technique. Artif Cells Blood Substit Immobil Biotechnol, 25:457–462.
   PubMed Web of Science ®Google Scholar
• Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. (1997). Flavor-masked pharmaceutical compositions. US 5695784.
   Google Scholar
• Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. (1999). Microencapsulated taste-masked pharmaceutical compositions. EP 551820 B1.
   Google Scholar
• Pöllinger N, Michaelis J, Benke K, Rupp R, Bücheler M. (2000). Flavor-masked pharmaceutical compositions. US 6136347.
   Google Scholar
• Becourt P, Chauvin J, Schwabe D. (2002). Pharmaceutical formulation having a masked taste comprising a cellulose polymer and a methacrylic polymer. WO 2003000225 A3.
   Google Scholar